2,301 results on '"Pileri, Stefano"'
Search Results
2. Correction to: Mediastinal large B cell lymphoma and surrounding gray areas: a report of the lymphoma workshop of the 20th meeting of the European Association for Haematopathology
3. Tumor microenvironment of Burkitt lymphoma: different immune signatures with different clinical behavior
4. Lymphomatoid Papulosis With T-cell Receptor–Gamma Delta Expression: A Clinicopathologic Case-series of 26 Patients of an Underrecognized Immunophenotypic Variant of Lymphomatoid Papulosis
5. Dysregulation of PRMT5 in chronic lymphocytic leukemia promotes progression with high risk of Richter’s transformation
6. Epidemiology of cutaneous T-cell lymphomas: state of the art and a focus on the Italian Marche region
7. Primary pulmonary T-cell lymphoproliferative disorders with a limited-stage, low proliferative index, and unusual clinical behavior: two cases of a rare occurrence
8. Romidepsin-CHOEP followed by high-dose chemotherapy and stem-cell transplantation in untreated Peripheral T-Cell Lymphoma: results of the PTCL13 phase Ib/II study
9. A Rare Case of BIA-ALCL Mass Associated with Mastectomy Skin Flap Erythema After Immunization with COVID-19
10. The SALENTO prognostic model for limited-stage peripheral T-cell lymphoma from the International T-Cell Project Network
11. Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCL
12. Diffuse large B-cell lymphomas, not otherwise specified, and emerging entities
13. Extranodal T- and NK-cell lymphomas
14. Gene expression profiling and FDG-PET radiomics uncover radiometabolic signatures associated with outcome in DLBCL
15. Histiocytic and dendritic cell neoplasms
16. Clonal T-cell proliferations occasionally occur in Kikuchi-Fujimoto disease
17. The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
18. DNMT3A mutations define a unique biological and prognostic subgroup associated with cytotoxic T cells in PTCL-NOS
19. The identification of TCF1+ progenitor exhausted T cells in THRLBCL may predict a better response to PD-1/PD-L1 blockade
20. A single-cell transcriptomic landscape of innate and adaptive intratumoral immunity in triple negative breast cancer during chemo- and immunotherapies
21. Genetic and phenotypic attributes of splenic marginal zone lymphoma
22. Dual targeting of the DNA damage response pathway and BCL-2 in diffuse large B-cell lymphoma
23. Histiocytic Neoplasma
24. Myeloid Sarcoma
25. Targeting CD30 in Patients with Hodgkin Lymphoma
26. Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma
27. A Spatially Resolved Dark- versus Light-Zone Microenvironment Signature Subdivides Germinal Center-Related Aggressive B Cell Lymphomas
28. Survival outcomes of patients with extranodal natural-killer T-cell lymphoma: a prospective cohort study from the international T-cell Project
29. Whole exome sequencing reveals mutations in FAT1 tumor suppressor gene clinically impacting on peripheral T-cell lymphoma not otherwise specified
30. Targeted DNA Damage Boost with Loncastuximab Tesirine in Combination with PARP Inhibitors in Diffuse Large B-Cell Lymphoma
31. The ATR inhibitor elimusertib exhibits anti‐lymphoma activity and synergizes with the PI3K inhibitor copanlisib
32. Massive parallel sequencing unveils homologous recombination deficiency in follicular dendritic cell sarcoma
33. Super-enhancer-based identification of a BATF3/IL-2R−module reveals vulnerabilities in anaplastic large cell lymphoma
34. Reproducing the molecular subclassification of peripheral T-cell lymphoma–NOS by immunohistochemistry
35. Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11
36. Novel markers in pediatric-type follicular lymphoma
37. CD30 expression in neoplastic T cells of follicular T cell lymphoma is a helpful diagnostic tool in the differential diagnosis of Hodgkin lymphoma
38. Identifying and addressing unmet clinical needs in primary cutaneous B‐cell lymphoma: A consensus‐based paper from an ad‐hoc international panel
39. S147: EFFICACY AND SAFETY RESULTS OF MOLTO, A MULTICENTER, OPEN LABEL, PHASE II CLINICAL TRIAL EVALUATING VENETOCLAX, ATEZOLIZUMAB AND OBINUTUZUMAB COMBINATION IN RICHTER SYNDROME
40. Targeting CD30 in Patients with Hodgkin Lymphoma
41. Granulysin, a novel marker for extranodal NK/T cell lymphoma, nasal type
42. Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas
43. A Microenvironment-Related Nine-Gene Signature May Predict Survival in Mycosis Fungoides Patients at Diagnosis
44. Mediastinal Gray-Zone Lymphoma: Still an Open Issue
45. [18F]‐FDG PET radiomic model as prognostic biomarker in diffuse large B‐cell lymphoma
46. Gray-Zone Lymphoma: A Still Open Issue
47. Lymphoproliferative Disorders Associated with Sjögren Syndrome
48. Pathology of nodal marginal zone lymphomas
49. Rituximab, bendamustine, and low-dose cytarabine as induction therapy in elderly patients with mantle cell lymphoma: a multicentre, phase 2 trial from Fondazione Italiana Linfomi
50. Reproducibility of SOX-11 detection in decalcified bone marrow tissue in mantle cell lymphoma patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.